We present a case of a 17-year-old man with first-episode schizophrenia who developed olanzapine-induced hepatitis, cholestasis, and splenomegaly, all of which were reversed after ceasing olanzapine. Clinicians prescribing olanzapine should be aware of this possible hepatotoxicity. Patient education, vigilance from clinicians, and careful clinical examination can help detect this complication early.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
olanzapine-induced hepatotoxicity
4
hepatotoxicity young
4
young chinese
4
chinese patient
4
patient case
4
case 17-year-old
4
17-year-old man
4
man first-episode
4
first-episode schizophrenia
4
schizophrenia developed
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!